Medgend Icon







discontinued


Belviq Xr FDA Approved Drugs

BELVIQ [Lorcaserin Hydrochloride]
RX
-
10mg (oral tablet)
Eisai IncJun 27, 2012
  • Method for chronic weight management by decreasing food intake in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by decreasing food intake.
  • Method for chronic weight management by inducing satiety in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by inducing satiety.
  • Method for chronic weight management by treating obesity in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by treating obesity.
  • Method for chronic weight management.
  • Method for chronic wieght management by controlling weight gain.
  • Use of belviq (lorcaserin hydrochloride) for chronic weight management by decreasing food intake in patients on a reduced-calorie diet and who have achieved greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of belviq (lorcaserin hydrochloride) for chronic weight management by inducing satiety in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of belviq (lorcaserin hydrochloride) for chronic weight management by treating obesity in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of belviq (lorcaserin hydrochloride) for chronic weight management in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BELVIQ XR [Lorcaserin Hydrochloride]
RX
-
20mg (oral tablet, extended release)
Eisai IncJul 15, 2016
  • Method for chronic weight management by decreasing food intake in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by decreasing food intake.
  • Method for chronic weight management by inducing satiety in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by inducing satiety.
  • Method for chronic weight management by treating obesity in an individual who does not have severe renal impairment or esrd.
  • Method for chronic weight management by treating obesity.
  • Method for chronic weight management.
  • Method for chronic wieght management by controlling weight gain.
  • Use of lorcaserin hydrochloride for chronic weight management by decreasing food intake in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of lorcaserin hydrochloride for chronic weight management by inducing satiety in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of lorcaserin hydrochloride for chronic weight management by treating obesity in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
  • Use of lorcaserin hydrochloride for chronic weight management in patients on a reduced-calorie diet and who have achieved a greater than or equal to 5% weight loss by week 12 of treatment.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.